Full metadata record
DC poleHodnotaJazyk
dc.contributor.authorKajdiž, Romana
dc.contributor.authorBojnec, Štefan
dc.date.accessioned2016-01-22T05:59:13Z
dc.date.available2016-01-22T05:59:13Z
dc.date.issued2014
dc.identifier.citationE+M. Ekonomie a Management = Economics and Management. 2014, č. 3, s. 27-34.cs
dc.identifier.issn1212-3609 (Print)
dc.identifier.issn2336-5604 (Online)
dc.identifier.urihttp://www.ekonomie-management.cz/download/1411803180_cbbc/03_DETERMINANTS+OF+PUBLIC+EXPENDITURES.pdf
dc.identifier.urihttp://hdl.handle.net/11025/17566
dc.format8 s.cs
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherTechnická univerzita v Libercics
dc.relation.ispartofseriesE+M. Ekonomie a Management = Economics and Managementcs
dc.rights© Technická univerzita v Libercics
dc.rightsCC BY-NC 4.0cs
dc.subjectcenová regulacecs
dc.subjectléčivé přípravkycs
dc.subjectlékařský předpiscs
dc.subjectmanagementcs
dc.subjectveřejné výdajecs
dc.subjectSlovinskocs
dc.titleDeterminants of public expenditures for medicinal products in non hospital consumption in Sloveniaen
dc.typečlánekcs
dc.typearticleen
dc.rights.accessopenAccessen
dc.type.versionpublishedVersionen
dc.description.abstract-translatedThe Slovenian government aims to regulate prices for medicinal products to manage and reduce public expenditures for medicinal products. This paper aims to investigate the association between the regulated wholesale prices of medicinal products and the public expenditures for medicinal products, and to estimate regression model for public expenditures for medicinal products in the non hospital consumption. In the empirical research are included 758 regulated prices for medicinal products prescribed by the outpatients’ department on a prescription (Rp) during the years 2003–2010, which are financed from public expenditures. The correlation and regression analyses are used in order to establish the association between the regulated wholesale prices for medicinal products and the public expenditures for medicinal products. The correlation analysis confirmed a strong positive correlation of the public expenditures for medicinal products with the number of Rp or the number of boxes on the Rp prescription, a weak correlation with the wholesale prices for medicinal products and with the classification lists of medicinal products. The multiple regression analysis confirmed a positive significant impact of the wholesale price of medicinal products and the number of Rp or the number of boxes on the Rp prescription, on the public expenditures for medicinal products. The research has confirmed the association of the public expenditures for medicinal products with the regulated wholesale prices for medicinal products. It has underlined the importance of the rational prescription and use of medicinal products. The explanatory variables included in the regression model for the public expenditures for medicinal products explained up to 94% of variability in the public expenditures for medicinal products.en
dc.subject.translatedprice regulationen
dc.subject.translatedmedicinal productsen
dc.subject.translatedprescriptionen
dc.subject.translatedmanagementen
dc.subject.translatedpublic expendituresen
dc.subject.translatedSloveniaen
dc.identifier.doidx.doi.org/10.15240/tul/001/2014-3-003
dc.type.statusPeer-revieweden
Vyskytuje se v kolekcích:Číslo 3 (2014)
Číslo 3 (2014)

Soubory připojené k záznamu:
Soubor Popis VelikostFormát 
03_DETERMINANTS OF PUBLIC EXPENDITURES.pdfPlný text215,22 kBAdobe PDFZobrazit/otevřít
Zobrazit minimální záznam Zobrazit statistiky


Použijte tento identifikátor k citaci nebo jako odkaz na tento záznam: http://hdl.handle.net/11025/17566

Všechny záznamy v DSpace jsou chráněny autorskými právy, všechna práva vyhrazena.

hledání
navigace
  1. DSpace at University of West Bohemia
  2. Publikace ZČU / UWB Publications
  3. Časopisy ZČU / UWB Journals
  4. Ekonomie a management
  5. 2014
  6. Číslo 3 (2014)